ciprofloxacin has been researched along with mezlocillin in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 10 (58.82) | 18.7374 |
| 1990's | 3 (17.65) | 18.2507 |
| 2000's | 3 (17.65) | 29.6817 |
| 2010's | 1 (5.88) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Anderson, KC; Kellogg, GE; Sarkar, A | 1 |
| Barriere, SL; Catlin, DH; Frost, RW; Noe, A; Orlando, PL | 1 |
| Alkan, M; Berger, S; Mark, Z; Rubinstein, E; Samra, Y | 1 |
| Peters, HJ | 1 |
| DiVincenzo, CA; O'Keefe, JP; Tatarowicz, W; Venezio, FR | 1 |
| Berrocal, CI; Berrocal, L; Pérez, JL; Riera, L; Valls, F | 1 |
| Heilmann, F; Heizmann, W; Werner, H | 1 |
| Baars, B; Cullmann, W; Opferkuch, W; Stieglitz, M | 1 |
| Mellinghoff, D; Shah, PM; Stille, W | 1 |
| Esposito, S; Gupta, A; Thadepalli, H | 1 |
| Cheng, N; Chow, AW; Whiting, JL | 1 |
| Goering, RV; Sanders, CC; Sanders, WE; Werner, V | 1 |
| Miller, LA; Poupard, JA; Rittenhouse, SF; Utrup, LJ | 1 |
| Bernhardt, H; Knoke, M; Schulz, K; Zimmermann, K | 1 |
17 other study(ies) available for ciprofloxacin and mezlocillin
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Computational analysis of structure-based interactions and ligand properties can predict efflux effects on antibiotics.
Topics: Anti-Bacterial Agents; beta-Lactams; Computational Biology; Drug Resistance, Bacterial; Hydrophobic and Hydrophilic Interactions; Ligands; Membrane Transport Proteins; Microbial Sensitivity Tests; Models, Molecular; Protein Binding; Protein Conformation; Quantitative Structure-Activity Relationship; Regression Analysis; Thermodynamics | 2012 |
Alteration in the pharmacokinetic disposition of ciprofloxacin by simultaneous administration of azlocillin.
Topics: Adult; Azlocillin; Chromatography, High Pressure Liquid; Ciprofloxacin; Drug Interactions; Half-Life; Humans; Male; Mezlocillin | 1990 |
In vitro activity of ciprofloxacin compared with other agents against recent hospital isolates.
Topics: Acinetobacter; Anti-Bacterial Agents; Anti-Infective Agents, Urinary; Azlocillin; Bacteria; Cefamandole; Cefotaxime; Cefsulodin; Ciprofloxacin; Citrobacter; Cloxacillin; Enterobacter; Escherichia coli; Gentamicins; Humans; Klebsiella pneumoniae; Mezlocillin; Penicillin Resistance; Proteus; Pseudomonas aeruginosa; Quinolines; Serratia marcescens; Shigella; Staphylococcus | 1986 |
Comparison of intravenous ciprofloxacin and mezlocillin in treatment of complicated urinary tract infection.
Topics: Anti-Infective Agents; Ciprofloxacin; Female; Humans; Injections, Intravenous; Male; Mezlocillin; Middle Aged; Quinolines; Urinary Tract Infections | 1986 |
Activity of ciprofloxacin against multiply resistant strains of Pseudomonas aeruginosa, Staphylococcus epidermidis, and group JK corynebacteria.
Topics: Actinomycetales; Cefotaxime; Ciprofloxacin; Gentamicins; Humans; Methicillin; Mezlocillin; Microbial Sensitivity Tests; Norfloxacin; Penicillin Resistance; Pseudomonas aeruginosa; Staphylococcus epidermidis; Ticarcillin; Vancomycin | 1986 |
A comparison of the in-vitro activity of seventeen antibiotics against Streptococcus faecalis.
Topics: Ampicillin; Anti-Bacterial Agents; Ciprofloxacin; Enterococcus faecalis; Mezlocillin; Microbial Sensitivity Tests; Norfloxacin | 1987 |
Evaluation of the Cobas Bact automated system for susceptibility testing of Enterobacteriaceae, Pseudomonas aeruginosa, and Enterococcus faecalis to azlocillin, mezlocillin, and ciprofloxacin compared to NCCLS and DIN standards.
Topics: Autoanalysis; Azlocillin; Ciprofloxacin; Enterobacteriaceae; Mezlocillin; Microbial Sensitivity Tests; Pseudomonas aeruginosa; Software | 1988 |
Comparative evaluation of recently developed quinolone compounds--with a note on the frequency of resistant mutants.
Topics: Acinetobacter; Ampicillin; Anti-Bacterial Agents; Bacteria; Cefotaxime; Ciprofloxacin; Enoxacin; Enterobacteriaceae; Enterococcus faecalis; Gentamicins; Haemophilus influenzae; Mezlocillin; Nalidixic Acid; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Penicillin Resistance; Pseudomonas aeruginosa; Quinolines; Staphylococcus aureus | 1985 |
[Ciprofloxacin in combination with other antimicrobial substances].
Topics: Anti-Bacterial Agents; Azlocillin; Bacteria; Ciprofloxacin; Drug Interactions; Imipenem; Mezlocillin; Microbial Sensitivity Tests; Thienamycins; Tobramycin | 1988 |
In vitro synergy of ciprofloxacin and three other antibiotics against Bacteroides fragilis.
Topics: Anti-Bacterial Agents; Bacteroides fragilis; Cefoxitin; Ciprofloxacin; Clindamycin; Drug Synergism; Mezlocillin; Microbial Sensitivity Tests | 1987 |
Interactions of ciprofloxacin with clindamycin, metronidazole, cefoxitin, cefotaxime, and mezlocillin against gram-positive and gram-negative anaerobic bacteria.
Topics: Bacteria, Anaerobic; Cefotaxime; Cefoxitin; Ciprofloxacin; Drug Interactions; Drug Synergism; Gram-Negative Anaerobic Bacteria; Gram-Positive Bacteria; In Vitro Techniques; Metronidazole; Mezlocillin | 1987 |
Selection of multiple antibiotic resistance by quinolones, beta-lactams, and aminoglycosides with special reference to cross-resistance between unrelated drug classes.
Topics: Amikacin; Aminoglycosides; Anti-Bacterial Agents; Cefotaxime; Ciprofloxacin; Enterobacter; Enterobacteriaceae; Humans; Klebsiella pneumoniae; Mezlocillin; Mutation; Nalidixic Acid; Norfloxacin; Penicillin Resistance; Quinolines | 1984 |
Evaluation of 500 gram negative isolates to determine the number of major susceptibility interpretation discrepancies between the Vitek and MicroScan Walkaway for 9 antimicrobial agents.
Topics: Ampicillin; Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Clavulanic Acid; Clavulanic Acids; Enterobacter; Escherichia coli; Imipenem; Klebsiella pneumoniae; Mezlocillin; Microbial Sensitivity Tests; Norfloxacin; Penicillins; Piperacillin; Proteus mirabilis; Pseudomonas aeruginosa; Quality Control; Reproducibility of Results; Sulbactam; Thienamycins; Ticarcillin | 1996 |
Influence of ciprofloxacin and other antimicrobial drugs on different Escherichia coli strains in continuous-flow cultures under aerobic and anaerobic conditions.
Topics: Aerobiosis; Anaerobiosis; Anti-Infective Agents; Cefotaxime; Cephalosporins; Ciprofloxacin; Colony Count, Microbial; Culture Media; Escherichia coli; Feces; Gentamicins; Mezlocillin; Penicillins | 1998 |